About
Berlin Heals Holding AG is a Swiss medical technology company founded in 2014, with a research and development subsidiary in Berlin, Germany. The company focuses on innovative treatments for heart failure, a serious condition where the heart struggles to pump enough blood. Their main product, the Cardiac Microcurrent Device (C-MIC), is an implantable electroceutical device designed to improve heart function in patients with heart failure. The C-MIC delivers a constant microcurrent to reduce inflammation and promote heart tissue remodeling. Clinical studies have shown significant improvements in heart function, heart size, and overall patient quality of life. The company is advancing its minimally invasive implantation procedure, moving towards outpatient cardiac catheterization to enhance accessibility for patients. Berlin Heals has achieved several clinical milestones, including a first-in-human pilot study and a randomized controlled trial. The C-MIC has received Breakthrough Device Designation and is part of the FDA's Total Product Life Cycle Advisory Program. The company aims to set a new standard of care for heart failure patients worldwide, focusing on reversing the disease process rather than just managing symptoms.
Technologies
Keywords
Company Information
-
Employees 24
-
Founded 2014
-
Total Funding $24641370
Location
Zug, Canton of Zug, Switzerland, 6300
